Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Tsubota Laboratory's Enterprise Value is 円5,805.9 Mil.
Tsubota Laboratory's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円0.0 Mil. Therefore, Tsubota Laboratory's EV-to-FCF for today is .
The historical rank and industry rank for Tsubota Laboratory's EV-to-FCF or its related term are showing as below:
TSE:4890'
s EV-to-FCF Range Over the Past 10 Years
Min: -948.25 Med: -24.65 Max: 46.77
Current: -9.06
During the past 7 years, the highest EV-to-FCF of Tsubota Laboratory was 46.77. The lowest was -948.25. And the median was -24.65.
TSE:4890's EV-to-FCF is ranked worse than 100% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.86
vs TSE:4890: -9.06
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Tsubota Laboratory's PE Ratio (TTM) for today is calculated as:
Tsubota Laboratory's share price for today is 円260.00.
Tsubota Laboratory's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-29.580.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Tsubota Laboratory EV-to-FCF Related Terms
Tsubota Laboratory EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Tsubota Laboratory's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tsubota Laboratory's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsubota Laboratory EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Tsubota Laboratory's EV-to-FCF falls into.
Tsubota Laboratory's current Enterprise Value is 円5,805.9 Mil.
Tsubota Laboratory's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?
Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued.
The current stock price of 円260.00 is trading 217.5% above its estimated GF Value™ of 円81.88.
GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.
Key valuation signals for TSE:4890:
EV-to-FCF:
GF Value™: 円81.88 vs. price of 円260.00 (217.5% above fair value)
No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
61GF Score
Get the complete analysis for TSE:4890
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4890 has been successfully added to your 
